Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry.

Lewczuk P, Riederer P, O'Bryant SE, Verbeek MM, Dubois B, Visser PJ, Jellinger KA, Engelborghs S, Ramirez A, Parnetti L, Jack CR Jr, Teunissen CE, Hampel H, Lleó A, Jessen F, Glodzik L, de Leon MJ, Fagan AM, Molinuevo JL, Jansen WJ, Winblad B, Shaw LM, Andreasson U, Otto M, Mollenhauer B, Wiltfang J, Turner MR, Zerr I, Handels R, Thompson AG, Johansson G, Ermann N, Trojanowski JQ, Karaca I, Wagner H, Oeckl P, van Waalwijk van Doorn L, Bjerke M, Kapogiannis D, Kuiperij HB, Farotti L, Li Y, Gordon BA, Epelbaum S, Vos SJB, Klijn CJM, Van Nostrand WE, Minguillon C, Schmitz M, Gallo C, Lopez Mato A, Thibaut F, Lista S, Alcolea D, Zetterberg H, Blennow K, Kornhuber J; Members of the WFSBP Task Force Working on this Topic: Peter Riederer, Carla Gallo, Dimitrios Kapogiannis, Andrea Lopez Mato, Florence Thibaut.

World J Biol Psychiatry. 2018 Jun;19(4):244-328. doi: 10.1080/15622975.2017.1375556. Epub 2017 Oct 27. Review.

PMID:
29076399
2.

Consensus paper of the WFSBP Task Force on Biological Markers: Criteria for biomarkers and endophenotypes of schizophrenia part I: Neurophysiology.

Thibaut F, Boutros NN, Jarema M, Oranje B, Hasan A, Daskalakis ZJ, Wichniak A, Schmitt A, Riederer P, Falkai P; WFSBP Task Force on Biological Markers.

World J Biol Psychiatry. 2015;16(5):280-90. doi: 10.3109/15622975.2015.1050061. Review.

PMID:
26213111
3.

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of eating disorders.

Aigner M, Treasure J, Kaye W, Kasper S; WFSBP Task Force On Eating Disorders.

World J Biol Psychiatry. 2011 Sep;12(6):400-43. doi: 10.3109/15622975.2011.602720. Review.

PMID:
21961502
4.

[Randomized, open label study on the use of ranitidine at different doses for the management of weight gain associated with olanzapine administration].

López-Mato A, Rovner J, Illa G, Vieitez A, Boullosa O.

Vertex. 2003 Jun-Aug;14(52):85-96. Spanish.

PMID:
12883589
5.

Psiquiatría psiconeuroinmunoendocrinológica.

Lopez-Mato AM, Boullosa O, Márquez C, Illa G, Vieitez A.

Vertex. 2001;XII(Suppl 1):14-25. Spanish. No abstract available.

PMID:
11781588
6.

[Psycho-neuro-immuno-endocrinological psychiatry].

Lopez-Mato AM, Boullosa O, Márquez C, Illa G, Vieitez A.

Vertex. 2001;12 Suppl 1:14-25. Review. Spanish. No abstract available.

PMID:
11780159

Supplemental Content

Loading ...
Support Center